The Effect of Oestrone on Mammary Tumors in Mice
Author Information
Author(s): B. D. Pullinger
Primary Institution: Royal Beatson Memorial Hospital, Glasgow
Hypothesis
Does oestrone treatment after ovariectomy affect the incidence of mammary carcinoma and adenoma in C3Hf mice?
Conclusion
Oestrone treatment after ovariectomy significantly increased the incidence of mammary carcinoma and adenoma in C3Hf mice.
Supporting Evidence
- 2 out of 30 mice treated with 5 µg of oestrone developed mammary carcinoma.
- 6 out of 23 mice treated with 10 µg of oestrone developed mammary carcinoma.
- 12 out of 18 mice treated with 5 µg of oestrone bore adenomatous nodules.
- 14 out of 14 mice treated with 10 µg of oestrone bore adenomatous nodules.
Takeaway
When female mice had their ovaries removed and then received a hormone called oestrone, more of them developed breast tumors.
Methodology
C3Hf mice were ovariectomized and treated with oestrone weekly for 30 weeks, with subsequent monitoring for tumor development.
Potential Biases
Potential bias in the selection of mice and the method of treatment application.
Limitations
The study did not test higher doses of oestrone due to observed health issues in treated mice.
Participant Demographics
C3Hf mice, specifically surplus breeders aged 9 to 11 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website